48 studies found for:    Open Studies | "Duodenal Diseases"
Show Display Options
Rank Status Study
1 Recruiting Endoscopic Characteristics of Duodenal and Ampullary Lesions
Condition: Duodenal Diseases
Intervention: Other: Tissue Sampling
2 Unknown  Surveillance of Bleeding Peptic Ulcer Using Wireless Capsule Endoscopy
Condition: Bleeding Peptic Ulcer
Intervention: Device: Endoscopic placement of Capsule endoscope adjacent to the peptic ulcer
3 Unknown  Comparison of Ulcer Healing in Patients Taking Rabeprazole With Different Antiplatelets
Conditions: Gastric Ulcer;   Duodenal Ulcer
Intervention: Drug: rabeprazole plus aspirin versus rabeprazole plus clopidogrel
4 Unknown  Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori
Conditions: Helicobacter Infections;   Gastritis;   Gastric Ulcer;   Duodenal Ulcer
Intervention: Drug: Lansoprazole, clarithromycin, amoxicillin
5 Recruiting Postoperative Oral Nutritional Supplementation After Major Gastrointestinal Surgery
Conditions: Gastric Cancer;   Colon Cancer;   Pancreatic Cancer;   Duodenal Cancer;   Biliary Cancer;   Peptic Ulcer;   Inflammatory Bowel Diseases
Intervention: Dietary Supplement: oral nutritional supplement
6 Recruiting Frequent Ketamine Use and Gastrointestinal, Liver and Biliary Sequelae
Conditions: Gastritis;   Peptic Ulcer Disease;   Cholangiopathy;   Liver Fibrosis
Intervention:
7 Recruiting Prevention of Gastric Ulcer Bleeding by Using "Computer-alert" in General Practice
Condition: Bleeding Peptic Ulcer
Interventions: Other: Computer-alert;   Device: A computer alerts which pops up when the GP presribes NSAID/ASA to a patient with risk-factors;   Device: Computer-alert
8 Recruiting Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer
Condition: Peptic Ulcer
Interventions: Drug: histamine-2 receptor antagonist (famotidine);   Drug: Placebo;   Drug: thienopyridine
9 Recruiting A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases
Conditions: Gastric Ulcer (GU);   Duodenal Ulcer (DU);   Anastomotic Ulcer (AU);   Non-erosive Reflux Esophagitis Disease (NERD);   Reflux Esophagitis (RE);   Zollinger-Ellison Syndrome
Interventions: Drug: D961H sachet 10 mg;   Drug: D961H capsule 10mg;   Drug: D961H capsule 20 mg
10 Recruiting Second-look Endoscopy in High Risk Patients After Endoscopic Hemostasis to Their Bleeding Peptic Ulcers Improves Their Outcomes
Condition: Ulcer Bleeding
Intervention: Procedure: epinephrine injection or heater probe or hemoclips
11 Recruiting Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders
Conditions: Ampullary Cancer;   Duodenal Cancer;   Bile Duct Cancer;   Bile Duct Disorders;   Gallstones;   Obstructive Jaundice;   Pancreatic Disorders (Noncancerous);   Colorectal Cancer;   Esophageal Cancer;   Barrett's Esophagus;   Gastric Malignancies;   Pancreatic Cancer;   Pediatric Gastroenterology;   Cholangiocarcinoma;   Pancreatic Pseudocysts;   Acute and Chronic Pancreatitis;   Recurrent Pancreatitis;   Cholangitis;   Bile Leak;   Biliary Strictures;   Pancreatic Divisum;   Biliary and Pancreatic Stones;   Choledocholithiasis
Intervention:
12 Recruiting Hemospray Versus the Combined Conventional Technique for Endoscopic Hemostasis of Bleeding Peptic Ulcers : A Pilot Study
Condition: Bleeding Peptic Ulcers
Interventions: Device: Hemospray;   Device: Combined Conventional Technique
13 Unknown  The Revolutions of Helicobacter Pylori Infection, Bacterial Density, and Histological Features After Antrectomy
Conditions: Helicobacter Pylori Infection;   Peptic Ulcer;   Bile Reflux;   Gastritis
Intervention:
14 Unknown  Peptic Ulcer Disease in Ischemic Heart Patients Taking Aspirin and Clopidogrel With or Without Proton Pump Inhibitor
Conditions: Peptic Ulcer;   Ulcer Complications
Interventions: Drug: lansoprazole;   Drug: aluminum hydroxide 334 mg and Mg hydroxide 166 mg
15 Recruiting The Efficacy of Double Doses of Oral Esomeprazole in Preventing Rebleeding and the Selection Criteria for Second-look Endoscopy for Patients With Bleeding Peptic Ulcers
Condition: Peptic Ulcer Bleeding
Intervention: Drug: esomeprazole (Nexium®, AstraZeneca AB, Södertälje, Sweden)
16 Recruiting DLBS2411 Treatment for Ulcer Healing in Non-Bleeding Peptic Ulcers
Condition: Non-Bleeding Peptic Ulcers
Interventions: Drug: Omeprazole;   Drug: Placebo caplet of DLBS2411;   Drug: DLBS2411;   Drug: Placebo capsule of Omeprazole
17 Unknown  Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection
Conditions: Helicobacter Infections;   Gastritis;   Gastric Ulcer;   Duodenal Ulcer
Intervention: Drug: rabeprazole, amoxicillin, clarithromycin, metronidazole
18 Recruiting WEI NASAL JET for The Sedation of Outpatient Upper Gastrointestinal Endoscopy
Conditions: Peptic Ulcer;   Gastric Cancer;   Esophagus Cancer;   Oesophagitis;   Hypoxia
Interventions: Device: WEI  NASAL JET;   Device: Nasopharyngeal airway without jet ventilator
19 Recruiting Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
Conditions: Gastritis;   Gastroduodenal Ulcer
Interventions: Drug: ALBIS;   Drug: Placebo
20 Recruiting H2RA VS PPI for the Prevention of Ulcer Bleeding Associated With Low-dose Aspirin in Patients With Very High Ulcer Risk
Condition: Peptic Ulcer Bleeding
Interventions: Drug: Rabeprazole;   Drug: Famotidine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years